Evolent Health
EVH
167 hedge funds and large institutions have $764M invested in Evolent Health in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 31 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
31% more capital invested
Capital invested by funds: $585M → $764M (+$179M)
0.54% more ownership
Funds ownership: 100.06% → 100.59% (+0.54%)
5% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 57
10% less call options, than puts
Call options by funds: $6.31M | Put options by funds: $6.99M
4% less funds holding
Funds holding: 174 → 167 (-7)
19% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.1M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$8.11M |
| 3 |
Bank of New York Mellon
New York
|
+$7.84M |
| 4 |
Millennium Management
New York
|
+$6.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$7.79M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$6.69M |
| 3 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$5.39M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$4.82M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.76M |
EVH Hedge Fund Activity: Q4 2019 in Review
167 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q4 2019, worth a combined $764M — up 31% from $585M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of EVH and 25 opened new positions — a net loss of 6 holders — while 57 trimmed existing stakes and 54 added.
The largest buyer was Wellington Management Group, adding an estimated $16.1M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $7.79M sold.
- 167 institutional investors held Evolent Health (EVH) as of Q4 2019, down from 174 in Q3 2019.
- Funds reported $764M of Evolent Health stock for Q4 2019, up 31% quarter-over-quarter.
- 25 funds opened new Evolent Health positions in Q4 2019 and 31 closed out, a net change of -6 holders.
- The largest Evolent Health buyer in Q4 2019 was Wellington Management Group, an estimated $16.1M added.
- The largest Evolent Health seller in Q4 2019 was Baillie Gifford & Co, an estimated $7.79M sold.
Based on aggregated 13F filings for Q4 2019.